S&P 500   4,467.71
DOW   35,123.36
QQQ   367.91
2 Tech Stocks to Buy and One to Avoid in August
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Stocks to Buy No Matter Which Way Inflation Moves
3 Stocks to Buy After Heavy Insider Buying
Ben Stein FREE Report: How Americans Are RUINING Retirement (Ad)
2 Alternatives To Tesla (1 Safe, 1 More Risky)
The Rivian Market Is About To Shift Into A Higher Gear 
Ben Stein FREE Report: How Americans Are RUINING Retirement (Ad)
7 Best Fintech ETFs to Buy Now
How major US stock indexes fared Wednesday, 8/9/2023
S&P 500   4,467.71
DOW   35,123.36
QQQ   367.91
2 Tech Stocks to Buy and One to Avoid in August
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Stocks to Buy No Matter Which Way Inflation Moves
3 Stocks to Buy After Heavy Insider Buying
Ben Stein FREE Report: How Americans Are RUINING Retirement (Ad)
2 Alternatives To Tesla (1 Safe, 1 More Risky)
The Rivian Market Is About To Shift Into A Higher Gear 
Ben Stein FREE Report: How Americans Are RUINING Retirement (Ad)
7 Best Fintech ETFs to Buy Now
How major US stock indexes fared Wednesday, 8/9/2023
S&P 500   4,467.71
DOW   35,123.36
QQQ   367.91
2 Tech Stocks to Buy and One to Avoid in August
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Stocks to Buy No Matter Which Way Inflation Moves
3 Stocks to Buy After Heavy Insider Buying
Ben Stein FREE Report: How Americans Are RUINING Retirement (Ad)
2 Alternatives To Tesla (1 Safe, 1 More Risky)
The Rivian Market Is About To Shift Into A Higher Gear 
Ben Stein FREE Report: How Americans Are RUINING Retirement (Ad)
7 Best Fintech ETFs to Buy Now
How major US stock indexes fared Wednesday, 8/9/2023
S&P 500   4,467.71
DOW   35,123.36
QQQ   367.91
2 Tech Stocks to Buy and One to Avoid in August
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Stocks to Buy No Matter Which Way Inflation Moves
3 Stocks to Buy After Heavy Insider Buying
Ben Stein FREE Report: How Americans Are RUINING Retirement (Ad)
2 Alternatives To Tesla (1 Safe, 1 More Risky)
The Rivian Market Is About To Shift Into A Higher Gear 
Ben Stein FREE Report: How Americans Are RUINING Retirement (Ad)
7 Best Fintech ETFs to Buy Now
How major US stock indexes fared Wednesday, 8/9/2023
NASDAQ:BNTC

Benitec Biopharma (BNTC) News Today

$3.20
+1.27 (+65.80%)
(As of 08/9/2023 ET)
Compare
Today's Range
$1.86
$4.84
50-Day Range
$1.93
$60.01
52-Week Range
$1.86
$18.02
Volume
26.02 million shs
Average Volume
313,383 shs
Market Capitalization
$5.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$68.00
SourceHeadline
marketbeat.com logo
marketbeat.com - August 9 at 10:42 AM
marketbeat.com logo
marketbeat.com - August 9 at 10:18 AM
msn.com logoBenitec Biopharma prices $30M equity offering
msn.com - August 9 at 7:04 AM
finance.yahoo.com logoBenitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public Offering
finance.yahoo.com - August 9 at 2:00 AM
msn.com logoBenitec Biopharma (BNTC) Price Target Increased by 1600.00% to 69.36
msn.com - August 2 at 5:12 AM
barrons.com logoBenitec Biopharma Inc.
barrons.com - July 28 at 10:17 AM
finance.yahoo.com logoBenitec Biopharma Announces 1-for-17 Reverse Stock Split Effective July 26, 2023
finance.yahoo.com - July 27 at 4:09 AM
marketbeat.com logo
marketbeat.com - July 26 at 10:23 AM
marketwatch.com logoBenitec Biopharma Receives FDA Clearance of IND for BB-301
marketwatch.com - June 26 at 10:30 PM
marketwatch.com logoBenitec Biopharma Shares Double on FDA Clearance
marketwatch.com - June 26 at 12:27 PM
msn.com logoWhat In The World Is Going On With Benetic Biopharma (BNTC) Stock
msn.com - June 26 at 12:27 PM
finance.yahoo.com logoBenitec Biopharma Receives FDA Clearance of the IND for BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy
finance.yahoo.com - June 26 at 12:27 PM
msn.com logoJMP Securities Reiterates Benitec Biopharma (BNTC) Market Outperform Recommendation
msn.com - May 18 at 11:36 AM
markets.businessinsider.com logoJMP Securities Remains a Buy on Benitec Biopharma (BNTC)
markets.businessinsider.com - May 18 at 6:35 AM
marketwatch.com logo8-K: Benitec Biopharma Inc.
marketwatch.com - May 16 at 4:19 PM
finanznachrichten.de logoBenitec Biopharma Inc.: Benitec Biopharma Releases Third Quarter 2023 Financial Results and Provides Operational Update
finanznachrichten.de - May 15 at 1:04 PM
finance.yahoo.com logoBenitec Biopharma Releases Third Quarter 2023 Financial Results and Provides Operational Update
finance.yahoo.com - May 15 at 1:04 PM
finance.yahoo.com logoBenitec Biopharma to Present at the JMP Securities Life Sciences Conference
finance.yahoo.com - May 8 at 11:22 AM
nbcnews.com logoMore than 200 drugmakers led by Pfizer blast Texas judge's abortion pill decision
nbcnews.com - April 14 at 8:26 AM
seekingalpha.com logoBNTC Benitec Biopharma Inc.
seekingalpha.com - March 1 at 12:10 PM
finanznachrichten.de logoBenitec Biopharma Inc.: Benitec Biopharma Releases Second Quarter 2023 Financial Results and Provides Operational Update
finanznachrichten.de - February 13 at 8:55 AM
finance.yahoo.com logoBenitec Biopharma Releases Second Quarter 2023 Financial Results and Provides Operational Update
finance.yahoo.com - February 13 at 8:55 AM
finance.yahoo.com logoBenitec Biopharma Enrolls First OPMD Subject into the Clinical Development Program
finance.yahoo.com - January 23 at 10:01 AM
finance.yahoo.com logoBiopharma Giants Gather at JPMorgan Conference After ‘Depressing’ Year
finance.yahoo.com - January 13 at 9:20 AM
finanznachrichten.de logoBenitec Biopharma Inc.: Benitec Biopharma Releases First Quarter 2023 Financial Results and Provides Operational Update
finanznachrichten.de - November 10 at 3:45 PM
finance.yahoo.com logoBenitec Biopharma Releases First Quarter 2023 Financial Results and Provides Operational Update
finance.yahoo.com - November 10 at 8:33 AM
finance.yahoo.com logoBenitec Biopharma Inc. Announces Closing of $18 Million Underwritten Public Offering
finance.yahoo.com - September 16 at 8:54 AM
finance.yahoo.com logoBenitec Biopharma Inc. Announces Pricing of $18 Million Underwritten Public Offering
finance.yahoo.com - September 13 at 3:08 AM
marketbeat.com logo
marketbeat.com - September 8 at 10:12 AM
finance.yahoo.com logoBenitec Biopharma Inc. (BNTC)
finance.yahoo.com - August 25 at 6:53 PM
finance.yahoo.com logoHaving purchased US$827k worth of Benitec Biopharma Inc. (NASDAQ:BNTC) stock, the recent 11% pullback is not what insiders may have expected
finance.yahoo.com - July 15 at 8:09 AM
marketwatch.com logoBenitec Biopharma Shares Surge 119%, to $1.62
marketwatch.com - June 24 at 5:11 PM
marketbeat.com logo
marketbeat.com - June 24 at 11:51 AM
marketbeat.com logo
marketbeat.com - June 24 at 11:31 AM
marketbeat.com logo
marketbeat.com - June 24 at 10:08 AM
marketbeat.com logo
marketbeat.com - June 24 at 10:00 AM
marketbeat.com logo
marketbeat.com - June 24 at 9:50 AM
marketbeat.com logo
marketbeat.com - June 24 at 9:43 AM
finance.yahoo.com logoBenitec Biopharma Releases Q3 2022 Financial Results
finance.yahoo.com - May 16 at 3:36 PM
finance.yahoo.com logoBenitec Biopharma Discloses Q2 2022 Financial Results
finance.yahoo.com - February 14 at 11:09 AM
finance.yahoo.com logo/C O R R E C T I O N from Source -- Norra Metals Corp./
finance.yahoo.com - January 18 at 5:57 PM
benzinga.com logoBenitec Biopharma 10%+ Owner Steven Michael Oliveira Reported Purchase of 331,877 Shares @ Avg Price of $4.51/Share in Form 4 Filing on Thursday
benzinga.com - December 11 at 4:58 PM
finance.yahoo.com logoBenitec Biopharma Discloses Q1 2022 Financial Results
finance.yahoo.com - November 15 at 9:56 AM
nasdaq.com logoWe're Keeping An Eye On Benitec Biopharma's (NASDAQ:BNTC) Cash Burn Rate
nasdaq.com - October 6 at 12:29 PM
marketbeat.com logo
marketbeat.com - September 22 at 1:07 PM
finance.yahoo.com logoBenitec Biopharma Provides Operational Update and Releases its 2021 Fiscal Year-End Financial Results
finance.yahoo.com - September 20 at 9:02 AM
finance.yahoo.com logoBenitec Biopharma to present at H.C. Wainwright's 23rd Annual Global Investment Conference
finance.yahoo.com - September 13 at 6:04 PM
finance.yahoo.com logoBenitec Biopharma Provides Positive Regulatory Updates for the BB-301 Development Program; BB-301 Phase 1b/2a Clinical Trial to Begin in 2022
finance.yahoo.com - September 8 at 6:12 PM
finance.yahoo.com logoBenitec Biopharma Provides Positive Updates on the BB-301 Pilot Dosing Study in Large Animals
finance.yahoo.com - September 8 at 6:12 PM
finance.yahoo.com logoBenitec Biopharma Provides Overview of the BB-301 Phase 1b/2a Clinical Trial Design for 2022
finance.yahoo.com - September 8 at 6:12 PM
Get Benitec Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for BNTC and its competitors with MarketBeat's FREE daily newsletter.



BNTC Media Mentions By Week

BNTC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BNTC
News Sentiment

0.60

0.42

Average
Medical
News Sentiment

BNTC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BNTC Articles
This Week

5

0

BNTC Articles
Average Week

Get Benitec Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for BNTC and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:BNTC) was last updated on 8/10/2023 by MarketBeat.com Staff

My Account -